Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,676Revenue $M1,319Net Margin (%)9.6Altman Z-Score3.0
Enterprise Value $M4,268EPS $2.7Operating Margin %13.7Piotroski F-Score7
P/E(ttm)29.3Beneish M-Score-2.4Pre-tax Margin (%)12.6Higher ROA y-yY
Price/Book5.510-y EBITDA Growth Rate %--Quick Ratio2.0Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %--Current Ratio2.3Lower Leverage y-yN
Price/Free Cash Flow20.6y-y EBITDA Growth Rate %9.6ROA % (ttm)6.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)18.7Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M47.4ROIC % (ttm)11.1Gross Margin Increase y-yY

Gurus Latest Trades with CRL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CRLKen Fisher 2015-06-30 Add0.01%$69.16 - $79.29
($74.08)
$ 77.625%Add 26.30%508,316
CRLDavid Dreman 2015-03-31 Reduce-0.31%$63.88 - $84.2
($73.77)
$ 77.625%Reduce 51.60%56,322
CRLRobert Olstein 2015-03-31 Sold Out -0.25%$63.88 - $84.2
($73.77)
$ 77.625%Sold Out0
CRLJohn Rogers 2015-03-31 Reduce-0.18%$63.88 - $84.2
($73.77)
$ 77.625%Reduce 12.26%1,758,445
CRLJoel Greenblatt 2015-03-31 Sold Out -0.0021%$63.88 - $84.2
($73.77)
$ 77.625%Sold Out0
CRLKen Fisher 2015-03-31 Add$63.88 - $84.2
($73.77)
$ 77.625%Add 5.05%402,466
CRLRobert Olstein 2014-12-31 Reduce-0.69%$56.46 - $65.59
($62.72)
$ 77.6224%Reduce 73.55%32,000
CRLJoel Greenblatt 2014-12-31 Buy $56.46 - $65.59
($62.78)
$ 77.6224%New holding4,028
CRLJoel Greenblatt 2014-09-30 Sold Out -0.01%$52.24 - $61.2
($57.34)
$ 77.6235%Sold Out0
CRLRobert Olstein 2014-06-30 Add0.38%$50.74 - $61.47
($54.9)
$ 77.6241%Add 64.20%133,000
CRLDavid Dreman 2014-06-30 Reduce-0.2%$50.74 - $61.47
($54.9)
$ 77.6241%Reduce 27.79%109,870
CRLKen Fisher 2014-06-30 Add0.02%$50.74 - $61.47
($54.9)
$ 77.6241%Add 76.46%371,824
CRLJoel Greenblatt 2014-06-30 Buy 0.01%$50.74 - $61.47
($54.9)
$ 77.6241%New holding11,280
CRLRobert Olstein 2014-03-31 Reduce-0.68%$52.88 - $62.01
($58.09)
$ 77.6234%Reduce 52.07%81,000
CRLJohn Rogers 2014-03-31 Reduce-0.4%$52.88 - $62.01
($58.09)
$ 77.6234%Reduce 23.58%2,009,262
CRLDavid Dreman 2014-03-31 Reduce-0.24%$52.88 - $62.01
($58.09)
$ 77.6234%Reduce 28.25%152,159
CRLJoel Greenblatt 2014-03-31 Sold Out -0.03%$52.88 - $62.01
($58.09)
$ 77.6234%Sold Out0
CRLKen Fisher 2014-03-31 Add0.02%$52.88 - $62.01
($58.03)
$ 77.6234%Add 288.19%210,712
CRLJoel Greenblatt 2013-12-31 Reduce-0.03%$44.67 - $53.36
($50.23)
$ 77.6255%Reduce 47.51%21,759
CRLDavid Dreman 2013-09-30 Reduce-0.74%$41.84 - $48.15
($45.95)
$ 77.6269%Reduce 74.82%187,877
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CRL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CRL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ACKERMAN THOMAS FCorporate Executive VP & CFO 2015-05-15Sell1,100$71.069.23view
ACKERMAN THOMAS FCorporate Executive VP & CFO 2015-05-15Sell3,900$70.5110.08view
MASSARO GEORGEDirector 2015-05-07Sell1,360$70.2110.55view
CHUBB STEPHEN DDirector 2015-05-01Sell2,000$69.811.2view
Crowley John JSVP, Chief Accounting Officer 2015-03-04Sell912$76.531.42view
CHUBB STEPHEN DDirector 2015-03-03Sell2,000$75.522.78view
Kochevar Deborah TurnerDirector 2015-03-02Sell2,600$76.591.34view
GILLETT NANCYCorporate Executive VP 2015-03-02Sell4,379$76.721.17view
FOSTER JAMES CChairman, President and CEO 2015-03-02Sell9,483$76.671.24view
FOSTER JAMES CChairman, President and CEO 2015-03-02Sell8,552$76.481.49view

Press Releases about CRL :

Quarterly/Annual Reports about CRL:

News about CRL:

Articles On GuruFocus.com
Carl Appoints Rick Sanderson to the Board of Directors Jun 30 2015 
Weekly Highlight of CEO Sells Oct 13 2014 
John Rogers Comments on Charles River Laboratories Intl Inc Jul 22 2014 
John Rogers' Ariel Fund Second Quarter 2014 Commentary Jul 22 2014 
Robert Olstein’s Largest New Stock Picks Feb 12 2013 
Weekly CFO Sells HIGHLIGHT: TMO, BLOX, VRSK, CRL, INGR, GWRE Jan 13 2013 
Ariel Funds Top Buys: "We think like Halvorsen: CRL is a buy" Jan 11 2012 
Stocks I Can Buy Much Cheaper Than Halvorsen Did Jan 11 2012 
Ken Heebner Top Holdings: AAPL Is a Buy at $380 Jan 11 2012 
Charles River Laboratories International Reports Operating Results (10-Q) Nov 04 2010 

More From Other Websites
10-Q for Charles River Laboratories International, Inc. Aug 01 2015
Edited Transcript of CRL earnings conference call or presentation 30-Jul-15 12:30pm GMT Jul 30 2015
Charles River misses 2Q profit forecasts Jul 30 2015
Charles River misses 2Q profit forecasts Jul 30 2015
Charles River Laboratories Announces Second-Quarter 2015 Results from Continuing Operations Jul 30 2015
Charles River Laboratories and AstraZeneca Renew Strategic Partnership Agreement Jul 30 2015
CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial... Jul 30 2015
Q2 2015 Charles River Laboratories International Inc Earnings Release - Before Market Open Jul 30 2015
Charles River Laboratories and AstraZeneca Renew Strategic Partnership Agreement Jul 30 2015
Charles River Laboratories Announces Second-Quarter 2015 Results from Continuing Operations Jul 30 2015
Charles River Laboratories Completes the Acquisition of Celsis International Ltd. Jul 24 2015
Charles River Laboratories Completes the Acquisition of Celsis International Ltd. Jul 24 2015
Charles River Laboratories (CRL) Stock Downgraded at Barclays Jul 10 2015
Analysts' Actions -- Ameriprise, Costco, Nokia and More Jul 10 2015
Barclays Cuts Charles River Labs, Sees Lack Of Demand Proof Over Long-Term Jul 10 2015
Charles River upgraded by BofA/Merrill Jul 10 2015
Carl Announces Completion of Private Placement Jul 09 2015
Why Charles River Labs spent $212M on a bacteria detection company Jul 09 2015
Charles River Laboratories to Acquire Celsis International Ltd. Jul 09 2015
Charles River Laboratories to Acquire Celsis International Ltd. Jul 09 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK